Surge in the number of fertility clinics across the world to drive the market

Infertility can be defined as the inability of an individual to reproduce by natural means. The causes of infertility are extremely diverse. It can be due to advancement of maternal age, disorders in the occurrence of ovulation, tubal occlusion or blockage, genetics, sexually transmitted infections, immune infertility, endometrial polyps, uterine fibroids, infertility due to male factors, endometriosis, and others. According to CDC, in the U.S., 1 in every 8 couples or approximately 12% of married women face complications to attain pregnancy. Around one third infertility cases are due to the female partner, another one third due to the male counterpart, and the remaining are attributed to both the partners or other unexplained infertility causes. Fertility rate has halved since 1960. Treatment options for infertility include education or spreading awareness, medications to assist the development of egg during the ovulation period, insemination, in vitro fertilization , and third party reproduction surgery.

Key Drivers, Restraints and Opportunities of Global Infertility Treatment Market
Increase in the number of cases of infertility can be attributed to rise in physical inactivity, continual shift toward sedentary lifestyle, improper fetal care, delayed pregnancy, smoking, excessive consumption of alcohol, stress, and others. Moreover, rise in prevalence of diabetes and obesity is the key factor contributing to the increase in rate of these conditions. Surge in the number of fertility clinics across the world coupled with advancement in technologies to treat infertility among both men and women drives the global infertility treatment market. Furthermore, increase in investments by the public and private sectors in the health care industry has led to a conducive environment for the growth of the global infertility treatment market. However, high cost of procedures associated with reproductive techniques and other factors such as decreased efficacy among elderly women are likely to be major restraints of the global infertility treatment market in the next few years.

The global infertility treatment market can be segmented based on product, procedure, patient type, end-user, and region. In terms of product, the infertility treatment market can be classified into equipment, media & consumables, and accessories. The equipment segment can be categorized into microscopes, sperm analyzer systems, imaging systems, micromanipulators systems, ovum aspiration pumps, cryosystems, incubators, gas analyzers, and laser systems. Based on procedure, the global infertility treatment market can be divided into assisted reproductive technology, artificial insemination, fertility surgery, and others. The assisted reproductive technology segment can be classified into in vitro fertilization, surrogacy, and intra-cytoplasmic sperm injection (ICSI). The artificial insemination segment can be categorized into intrauterine insemination, intracervical insemination, and intratubal insemination. The fertility surgery segment can be divided into myomectomy, laparoscopy, hysteroscopy, varicocelectomy, laparotomy, tubal ligation reversal, and microsurgical reconstruction. In terms of patient type, the infertility treatment market can bifurcated into male and female. Based on end-user, the global infertility treatment market can be classified into hospitals & surgical clinics, fertility centers, research institutes, and cryobanks.

Key Players Operating in Global Infertility Treatment Market
Key players operating in the global infertility treatment market include Cook Group Incorporated, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne, Ltd., Ihmedical A/S, Irvine Scientific (A Member of Jx Holdings Group), IVFTech Aps, Kitazato Corporation, Medgyn Products, Inc., and Rocket Medical plc. BioSpace